Human Metabolome Technologies (TSE:6090) Cyclically Adjusted Book per Share: 円295.72 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6090 Human Metabolome Technologies Inc TSE:6090
62 GF Score
Price 円645.00
GF Value 円693.69
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Human Metabolome Technologies Cyclically Adjusted Book per Share?

Human Metabolome Technologies TSE:6090 +3.37% 62 Cyclically Adjusted Book per Share is 円295.72 as of Mar. 2026. GuruFocus rates TSE:6090 with a GF Score™ of 62/100 and a GF Value™ of 円693.69 (Fairly Valued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Human Metabolome Technologies's adjusted book value per share for the three months ended in Mar. 2026 was 円338.652. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円295.72 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Human Metabolome Technologies's average Cyclically Adjusted Book Growth Rate was 1.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-26), Human Metabolome Technologies's current stock price is 円645.00. Human Metabolome Technologies's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was 円295.72. Human Metabolome Technologies's Cyclically Adjusted PB Ratio of today is 2.18.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Human Metabolome Technologies was 2.83. The lowest was 1.95. And the median was 2.34.


Human Metabolome Technologies  (TSE:6090) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Human Metabolome Technologies's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=645.00/295.72
=2.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Human Metabolome Technologies was 2.83. The lowest was 1.95. And the median was 2.34.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Human Metabolome Technologies Cyclically Adjusted Book per Share Related Terms


Human Metabolome Technologies Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Human Metabolome Technologies's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Human Metabolome Technologies Cyclically Adjusted Book per Share Chart

Human Metabolome Technologies Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 267.31 281.82 292.71

Human Metabolome Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 292.71 293.05 295.74 295.72 0.00

TSE:6090 vs TMO, DHR, IDXX: Cyclically Adjusted Book per Share Comparison

For the Diagnostics & Research subindustry, Human Metabolome Technologies's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Human Metabolome Technologies Cyclically Adjusted PB Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Human Metabolome Technologies's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Human Metabolome Technologies's Cyclically Adjusted PB Ratio falls into.


TSE:6090
62GF Score
Human Metabolome Technologies Inc TSE:6090
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Human Metabolome Technologies Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Human Metabolome Technologies's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=338.652/112.7000*112.7000
=338.652

Current CPI (Mar. 2026) = 112.7000.

Human Metabolome Technologies Quarterly Data

Book Value per Share CPI Adj_Book
201603 285.579 97.900 328.751
201606 306.602 98.100 352.233
201609 300.948 98.000 346.090
201612 299.434 98.400 342.949
201703 320.036 98.100 367.666
201706 298.249 98.500 341.245
201709 283.072 98.800 322.897
201712 274.911 99.400 311.695
201803 300.586 99.200 341.492
201806 280.402 99.200 318.562
201809 253.969 99.900 286.510
201812 230.006 99.700 259.997
201903 245.603 99.700 277.627
201906 207.455 99.800 234.270
201909 193.565 100.100 217.930
201912 189.628 100.500 212.648
202003 225.611 100.300 253.503
202006 206.117 99.900 232.526
202009 199.933 99.900 225.550
202012 205.600 99.300 233.345
202103 221.059 99.900 249.383
202106 213.581 99.500 241.915
202109 204.049 100.100 229.733
202112 225.740 100.100 254.155
202203 257.611 101.100 287.169
202206 251.962 101.800 278.940
202209 248.802 103.100 271.969
202212 263.546 104.100 285.318
202303 289.882 104.400 312.928
202306 300.039 105.200 321.430
202309 280.594 106.200 297.768
202312 299.153 106.800 315.679
202403 326.145 107.200 342.878
202406 329.059 108.200 342.744
202412 325.405 110.700 331.284
202503 355.775 111.100 360.899
202506 335.312 111.700 338.314
202509 297.885 112.000 299.747
202512 321.227 113.000 320.374
202603 338.652 112.700 338.652

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of 円295.72 mean?
Human Metabolome Technologies (TSE:6090) has a Cyclically Adjusted Book per Share of 円295.72 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Human Metabolome Technologies and its competitors.
Is Human Metabolome Technologies' Cyclically Adjusted Book per Share too high?
Human Metabolome Technologies' current Cyclically Adjusted Book per Share is 円295.72. Overall, Human Metabolome Technologies has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Human Metabolome Technologies' Cyclically Adjusted Book per Share compare to TMO and DHR?
Human Metabolome Technologies' Cyclically Adjusted Book per Share of 円295.72 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Book per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Human Metabolome Technologies and its competitors. Human Metabolome Technologies's current Cyclically Adjusted Book per Share is 円295.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Human Metabolome Technologies stock overvalued right now?
Based on GuruFocus' analysis, Human Metabolome Technologies (TSE:6090) is currently considered Fairly Valued. The stock's GF Value™ is 円693.69, compared to a current price of 円645.00 — trading 7% below its estimated fair value. The current Cyclically Adjusted Book per Share is 円295.72. Human Metabolome Technologies' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Human Metabolome Technologies (TSE:6090), the current Cyclically Adjusted Book per Share is 円295.72 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Human Metabolome Technologies (TSE:6090) Overvalued in 2026?

Based on GuruFocus' analysis, Human Metabolome Technologies stock appears to be undervalued. The current stock price of 円645.00 is trading 7% below its estimated GF Value™ of 円693.69. GuruFocus considers Human Metabolome Technologies to be Fairly Valued.

Key valuation signals for TSE:6090:

  • Cyclically Adjusted Book per Share: 円295.72
  • GF Value™: 円693.69 vs. price of 円645.00 (7% below fair value)
  • GF Score™: 62/100 with 3 warning signs

No single metric tells the full story. See the TSE:6090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Human Metabolome Technologies Business Description

Address Yamagata Prefecture Kakuganji Water 246-2, Tsuruoka, JPN, 997-0052
Human Metabolome Technologies Inc is involved in the search and diagnosis of biomarkers and commercialization in the field of drug development.
62GF Score

Get the complete analysis for TSE:6090

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円645.00
Price
円693.69
GF Value